This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America. Active years: 2007-2009.
Location History:
- Berlin, DE (2007)
- Washington, DC (US) (2007 - 2009)
- Bethesda, MD (US) (2009)
Company Filing History:
3 out of 3,690 
1 out of 255 
Years Active: 2007-2009
Title: Alexander C Schmidt: Innovator in Vaccine Development
Introduction
Alexander C Schmidt is a prominent inventor based in Washington, DC. He has made significant contributions to the field of vaccine development, particularly in the area of parainfluenza virus (PIV) vaccines. With a total of 4 patents to his name, Schmidt's work has the potential to impact public health positively.
Latest Patents
Schmidt's latest patents focus on attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines. These chimeric human-bovine PIVs are designed to be infectious and attenuated in humans and other mammals. They are useful individually or in combination in vaccine formulations aimed at eliciting an immune response to PIV or other pathogens. The patents also include isolated polynucleotide molecules and vectors that incorporate a chimeric PIV genome or antigenome. This genome includes a partial or complete human or bovine PIV 'background' genome combined with one or more heterologous gene(s) or genome segment(s) from different PIV viruses.
Career Highlights
Throughout his career, Schmidt has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in these institutions has allowed him to contribute significantly to vaccine research and development.
Collaborations
Schmidt has collaborated with esteemed colleagues such as Brian R Murphy and Peter L Collins. These partnerships have further enhanced his research and innovation in the field of vaccine development.
Conclusion
Alexander C Schmidt is a key figure in the advancement of vaccine technology, particularly through his innovative work on chimeric parainfluenza virus vaccines. His contributions are vital for the ongoing efforts to improve public health through effective vaccination strategies.